143

Neurology
Focuses on brain health.
Sub Categories on Neurology
Latest Articles
How to fast safely during Ramadan: What the science shows

How to fast safely during Ramadan: What the science shows

by Feisal Subhan,The ConversationCredit: Pixabay/CC0 Public DomainFor1.9 billion Muslims, Ramadan is the ninth and holiest Islamic month and this year starts on March 11. During the 30 day

How to fast safely during Ramadan: What the science shows

by Feisal Subhan,The ConversationCredit: Pixabay/CC0 Public DomainFor1.9 billion Muslims, Ramadan is the ninth and holiest Islamic month and this year starts on March 11. During the 30 day
Risk factors for Parkinson's disease: Study proves the protective function of the RIT2 gene

Risk factors for Parkinson's disease: Study proves the protective function of the RIT2 gene

by Eurac ResearchIn vivo aSyn overexpression increases endogenous LRRK2 activity, which is prevented by Rit2 co-expression.aPLA analysis of AAV-GFP, AAV-A53T-aSyn and AAV-A53T-aSyn + AAV-R

Risk factors for Parkinson's disease: Study proves the protective function of the RIT2 gene

by Eurac ResearchIn vivo aSyn overexpression increases endogenous LRRK2 activity, which is prevented by Rit2 co-expression.aPLA analysis of AAV-GFP, AAV-A53T-aSyn and AAV-A53T-aSyn + AAV-R
Memory may be preserved in condition with brain changes similar to Alzheimer's disease

Memory may be preserved in condition with brain changes similar to Alzheimer's disease

by American Academy of NeurologyCredit: Unsplash/CC0 Public DomainPrimary progressive aphasia is a rare neurodegenerative condition characterized by prominent language problems that worsen over t

Memory may be preserved in condition with brain changes similar to Alzheimer's disease

by American Academy of NeurologyCredit: Unsplash/CC0 Public DomainPrimary progressive aphasia is a rare neurodegenerative condition characterized by prominent language problems that worsen over t
Magnetic resonance imaging shows brain inflammation in vivo for the first time

Magnetic resonance imaging shows brain inflammation in vivo for the first time

by Spanish National Research Council (CSIC)Researchers from the UMH-CSIC Neurosciences Institute have developed an innovative strategy that allows imaging of microglial and astrocyte activation in the

Magnetic resonance imaging shows brain inflammation in vivo for the first time

by Spanish National Research Council (CSIC)Researchers from the UMH-CSIC Neurosciences Institute have developed an innovative strategy that allows imaging of microglial and astrocyte activation in the
Alzheimer's disease impacts women in higher numbers and different ways

Alzheimer's disease impacts women in higher numbers and different ways

by Leigh Hopper,University of Southern CaliforniaAlzheimer’s disease strikes far more women than men, and the reason for this discrepancy isn’t yet known. Credit: PixabayNovember is Alzheimer&#3

Alzheimer's disease impacts women in higher numbers and different ways

by Leigh Hopper,University of Southern CaliforniaAlzheimer’s disease strikes far more women than men, and the reason for this discrepancy isn’t yet known. Credit: PixabayNovember is Alzheimer&#3
Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&

Solanezumab does not slow cognitive decline in preclinical Alzheimer disease

by Elana GotkineFor patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in theNew England Journal of Medicine&
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval
Synapse discovery could lead to new treatments for Alzheimer's disease

Synapse discovery could lead to new treatments for Alzheimer's disease

by University of New South WalesDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A team of researchers led by UNSW Australia scientists has discovere

Synapse discovery could lead to new treatments for Alzheimer's disease

by University of New South WalesDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.A team of researchers led by UNSW Australia scientists has discovere
Altered gut bacteria may be early sign of Alzheimer's disease

Altered gut bacteria may be early sign of Alzheimer's disease

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainPeople in the earliest stage of Alzheimer's disease—after brain changes have begun but before cognitive symptoms b

Altered gut bacteria may be early sign of Alzheimer's disease

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainPeople in the earliest stage of Alzheimer's disease—after brain changes have begun but before cognitive symptoms b
Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39

Treatment of metabolic dysfunction could be a potential therapy for Alzheimer's disease

by Yale-NUS CollegeCredit: CC0 Public DomainA team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.Alzheimer&#39
How aggression-promoting brain peptide works in fruit flies

How aggression-promoting brain peptide works in fruit flies

by Salk InstituteA fruit fly brain showing male-specific tachykininergic neurons (magenta), which make the neuropeptide tachykinin, and neurons that express TkR86C (green), which receive tachykin

How aggression-promoting brain peptide works in fruit flies

by Salk InstituteA fruit fly brain showing male-specific tachykininergic neurons (magenta), which make the neuropeptide tachykinin, and neurons that express TkR86C (green), which receive tachykin
Dementia found to be the dominant risk factor for COVID in elderly care

Dementia found to be the dominant risk factor for COVID in elderly care

by University of GothenburgHazard ratios (HR) and 95% Confidence intervals (CI) of the relationship between individual-level factors (age, sex, education, dementia, cardiovascular disease, lung d

Dementia found to be the dominant risk factor for COVID in elderly care

by University of GothenburgHazard ratios (HR) and 95% Confidence intervals (CI) of the relationship between individual-level factors (age, sex, education, dementia, cardiovascular disease, lung d